Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(26 sites)
United States
Stanford University, Palo Alto, California Grand Valley Oncology, Grand Junction, Colorado Florida Cancer Specialists & Research Institute, Lake Mary, Florida Sylvester Comprehensive Cancer Center, Miami, Florida University Chicago Medicine, Chicago, Illinois